XERIS BIOPHARMA HOLDINGS, INC. (XERS) Operating income 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) annual operating income history from SEC filings — each fiscal year as reported.
$24.9MFY2025 · since FY2020: -$83.5M → $24.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24.9M | +174.0% |
| FY2024 | -$33.6M | +23.5% |
| FY2023 | -$44.0M | +46.3% |
| FY2022 | -$81.9M | +28.8% |
| FY2021 | -$115.2M | -37.8% |
| FY2020 | -$83.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice